Literature DB >> 24438168

Prognostic factors in patients with terminal stage lung cancer.

Ryo Matsunuma1, Yuichi Tanbo, Nobuhiro Asai, Yoshihiro Ohkuni, Satoshi Watanabe, Shinya Murakami, Yukimitsu Kawaura, Kazuo Kasahara.   

Abstract

BACKGROUND: Lung cancer is the leading cause of cancer-related death.(1) Accurate prediction of survival in the terminal stage is important, because it may help patients make a rational decision. Although several prognostic scores have been described as effective indicators of outcome, these scores were intended for patients with other types of cancers. There is no prognostic score for patients with terminal-stage lung cancer.
OBJECTIVE: The aim of this study was to determine prognostic factors for patients with terminal-stage lung cancer. SETTING/
SUBJECTS: Patients in our palliative care unit (PCU) were selected retrospectively and divided into two independent groups, training and testing. Univariate and multivariate analyses were performed on data from the training group to detect independent prognostic factors, while data from patients in the testing group were analyzed to validate whether these prognostic factors predicted near-term death.
RESULTS: Ninety-three patients (69 in the training group and 24 in the testing group) were included in the analyses. Multivariate analysis showed that fatigue, anorexia, desaturation, hyponatremia, and hypoalbuminemia were independent prognostic factors in the training group. Mean survival time in patients who had more than three of these five factors was 9.2±2.6 days (p=0.012). In the testing group, the presence of more than three of these five factors predicted death within two weeks, with a sensitivity of 100% and specificity of 75%.
CONCLUSIONS: This study revealed that fatigue, anorexia, desaturation, hyponatremia, and hypoalbuminemia may be short-term prognostic factors in terminally ill lung cancer patients. In particular, the presence of more than three of these factors predicted death within two weeks.

Entities:  

Mesh:

Year:  2014        PMID: 24438168     DOI: 10.1089/jpm.2013.0448

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  3 in total

1.  Prevalence of hyponatremia in inpatients with incurable and life-limiting diseases and its association with physical symptoms-a retrospective descriptive study.

Authors:  Kerstin Kremeike; Ricarda M L Wetter; Volker Burst; Raymond Voltz; Kathrin Kuhr; Steffen T Simon
Journal:  Support Care Cancer       Date:  2017-08-18       Impact factor: 3.603

2.  The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients.

Authors:  Jorge J Castillo; Ilya G Glezerman; Susan H Boklage; Joseph Chiodo; Beni A Tidwell; Lois E Lamerato; Kathy L Schulman
Journal:  BMC Cancer       Date:  2016-07-29       Impact factor: 4.430

3.  Period from Loss of the Ability to Access Toilets Independently to Death in End-Stage Cancer Patients.

Authors:  Ryoichi Ichihashi; Kouichi Tanabe; Kenta Horio; Kunihiro Tsuchiya; Setsuko Hirata; Kaori Gassho; Kazuyo Yasuda; Akina Ishikawa; Kazuki Sato; Tatsuya Morita; Takuya Saiki
Journal:  J Palliat Med       Date:  2018-07-16       Impact factor: 2.947

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.